On the heels of Ukraine’s 2009 Black Lung Infection, a mysterious variation of flu which bypassed trachea, targeting the lungs directly, a “bilateral pneumonia, the result of viral distress syndrome, i.e the total destruction of the lungs.” (1.3 million infected, over 75,000 hospitalized), eye witness reports of Gov’t aerial spraying shortly before initial outbreaks from […]
Read More...Posts in the "Vaccine Info" Category
-
-
GlaxoSmythKline recently conducted safety trial studies on their new experimental Genital Herpes vaccine ‘Simplirix’. 8,323 women aged 18-30 years participated in the trial at 50 sites in the US & Canada. Based on the results the product has failed miserably. The question is why were these women infected with Herpes after vaccination with the virus? […]
Read More... -
VACCINE INDUSTRY COVER-UP EXPOSED – Selected vaccine authorities from CDC, FDA, and manufacturers gathered together in June of 2000, in a closed meeting (the Simpsonwood Retreat) to discuss growing concerns over the risk of neurological damage and neurodevelopmental disorders resulting from vaccine components. Documents released through the Freedom of Information Act reveal detailed minutes of members of […]
Read More... -
Canadian health practitioners should soon expect a flood of adverse reactions to this year’s flu shot ‘Fluviral’. Not only does this GSK produced vaccine contain twice the Industry standard for Thimerosal considered to be at an “acceptable” level, formaldehyde, multiple toxic buffers & detergent; but with addition of H1N1 sub-units, and based on the 2009 […]
Read More... -
In the race to the top of the Vaccine manufacturing foodchain product side effects such as infertility are being overlooked in favor of scientific advancement. One competitor, U.S. firm Celldex Theraputics are vying for major positioning in the ranks with a radical new generation cancer vaccine now in development for the treatment of advanced colorectal, […]
Read More... -
The United States flu vaccine for 2010-2011/AFLURIA® will be manufactured by CSL Laboratories in partnership with Merck Pharmaceuticals. Ingredients: 24.5 mcg of thimerosal mercury (safe level for a 550 pound adult), Neomycin & Polymyxin (antibiotics associated with Kidney Failure, hazardous to fetus), 3 strains of flu virus including A/Brisbane/59/2007 (H1N1 subunits). http://preventdisease.com/news/pdf/CSL_2009_LatestAfluriaPackageInsert_ucm112730.pdf CSL/MERCK PARTNERSHIP – […]
Read More... -
Quinvaxem, a powerful 5 in 1 vaccine currently being distributed in India, containing live Diphtheria, Tetanus, Hib oligosaccharide (Haemophilus influenzae) & Hepatitis B viruses plus an inactivated B. Pertussis virus (heat treated or attenuated), has already caused the deaths of at least 5 children in Sri Lanka according to the WHO, 8 children in Bhutan […]
Read More... -
VACCINE SURPLUS FROM 2009 – Canada: $200,000,000+ worth of unused H1N1 vaccine. United States: $455,000,000+ worth of unused H1N1 vaccine. France: approximately $750,000,000 worth of unused H1N1 vaccine supply. Britain: $250,000,000 worth of unused H1N1 vaccine supply (3.8 million doses). Germany: $300,000,000 (approximately 48 million doses wasted). Italy: $260,000,000 worth of H1N1 vaccine supply unused […]
Read More... -
Vaccine Resistance Movement is a grass roots, non-profit organization striving for safe alternatives to vaccines; both empowering citizens around the world with the means of self sufficiency while determined to expose vaccine fraud & pharmaceutical industry malfeasance. This study is the culmination of two years of inspired research, energized with the support of a growing […]
Read More... -
A substantial new Bill to require meningitis vaccine for 7th graders and ALL college students is gaining momentum in Albany, New York http://www.healthfreedomusa.org/?p=5472 Bill S7156 passed the Senate Health Committee and is due for a floor vote. Bill A10313 will be voted on the Assembly Health Committee any given Tuesday. http://www.ncsl.org/IssuesResearch/Health/MeningitisLegislationandLaws/tabid/13960/Default.aspx Assuming this Bill is […]
Read More...